Gilead Sciences – RiskReversal

Mike & Mark: Time to Get Long Gilead (GILD)?

January 5, 2017 by Mike Khouw • Trade Ideas

After a 1.5-Year Selloff, It’s time to Get Long Gilead Sciences, Inc. (GILD) Gilead Sciences, Inc. (GILD) is a research-based biopharmaceutical company. Through research and development they discover, develop, and commercialize innovative medicines designed to …

What’s the Story?

May 11, 2012 by CC • Commentary

Reuters JPMorgan Chase & Co’s shock trading loss of at least $2 billion from a failed hedging strategy knocked financial stocks across the globe on Friday, as well as the reputation of the biggest U.S. …

What’s the Story?

February 3, 2012 by CC • Commentary

NYT The United States economy gained momentum in January, adding 243,000 jobs, the second straight month of better-than-expected gains. The unemployment rate fell to 8.3 percent, giving a cause for optimism as the economy shapes …